tiprankstipranks
Trending News
More News >
Corline Biomedical AB (SE:CLBIO)
:CLBIO
Sweden Market

Corline Biomedical AB (CLBIO) Income Statement

Compare
0 Followers

Corline Biomedical AB Income Statement

Last quarter (Q4 2025), Corline Biomedical AB's total revenue was kr2.10M, an increase of 4.57% from the same quarter last year. In Q4, Corline Biomedical AB's net income was kr-5.03M. See Corline Biomedical AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 7.65Mkr 9.78Mkr 25.03Mkr 23.55Mkr 7.06M
Gross Profit
kr -14.21Mkr 13.44Mkr 28.38Mkr 22.73Mkr 9.10M
Operating Expenses
kr 0.00kr 36.61Mkr 30.17Mkr 20.40Mkr 11.13M
Depreciation and Amortization
kr 84.00Kkr 95.00Kkr 97.00Kkr 56.00Kkr 31.00K
EBITDA
kr -14.12Mkr -23.07Mkr -1.69Mkr 2.38Mkr -6.88M
Operating Income
kr -14.21Mkr -23.17Mkr -1.79Mkr 2.33Mkr -6.91M
Other Income/Expenses
kr -506.00Kkr -28.00Kkr -21.00Kkr 0.00kr -13.00K
Pretax Income
kr -14.71Mkr -23.19Mkr -1.81Mkr 2.33Mkr -6.92M
Net Income
kr -14.71Mkr -23.19Mkr -1.81Mkr 2.33Mkr -6.92M
Per Share Metrics
Basic EPS
kr -0.59kr -1.06kr -0.08kr 0.11kr -0.34
Diluted EPS
kr -0.59kr -1.06kr -0.08kr 0.11kr -0.34
Weighted Average Shares Outstanding
24.73M 21.81M 21.49M 21.49M 20.44M
Weighted Average Shares Outstanding (Diluted)
24.73M 21.81M 21.68M 21.49M 20.44M
Currency in SEK

Corline Biomedical AB Earnings and Revenue History